Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?

L van Iersel; HM van Santen; null Zandwijken; N Zwaveling-Soonawala; Anita Hokken - Koelega; ASP van Trotsenburg

doi:10.1159/000486033

Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?

L van Iersel, HM van Santen, Zandwijken, N Zwaveling-Soonawala, Anita Hokken - Koelega, ASP van Trotsenburg

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

4 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	98-107
Number of pages	10
Journal	Hormone Research in Paediatrics
Volume	89
Issue number	2
DOIs	https://doi.org/10.1159/000486033
Publication status	Published - 2018

Access to Document

10.1159/000486033

REPUB_104182-OA.pdfFinal published version, 364 KB

http://hdl.handle.net/1765/104182

Cite this

@article{2ceaf2465cd44fdbb7a365bc6a234944,

title = "Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?",

author = "{van Iersel}, L and {van Santen}, HM and Zandwijken and N Zwaveling-Soonawala and {Hokken - Koelega}, Anita and {van Trotsenburg}, ASP",

year = "2018",

doi = "10.1159/000486033",

language = "Undefined/Unknown",

volume = "89",

pages = "98--107",

journal = "Hormone Research in Paediatrics",

issn = "1663-2818",

publisher = "Karger",